Medical composition for treating climacteric syndrome and preparation thereof

Abstract

The invention relates to Chinese herbal compound treatment and discloses a medical composition for treating climacteric syndrome. The medical composition comprises the following components and contents in parts by weight: 1-3 parts of cassia twigs, 0.5-2 parts of Rhizoma Zingiberis, 2-4 parts of fructus schizandrae, 2-4 parts of Inula japonica, 3.5-5 parts of Lophatherum gracile, 2-4 parts of cortex moutan radicis, 0.5-2 parts of Chinese Date, 2-4 parts of Fried jujube, 2-4 parts of Cornus officinalis, 2-4 parts of Rhizome of rehmannia, 2-4 parts of Codonopsis pilosul, and 0.5-2cape jasmine. By means of the synergistic effect of the sixteen ingredients, the medical composition has following beneficial effects: tonifying liver and qi, nourishing blood and tranquilization, clearing deficient heat and relieving restlessness. The invention also discloses a preparation method for the medical composition for treating climacteric syndrome. The method is convenient; preparation condition is simple; the method is safe and reliable which is suitable for industrial production.

Description

technical field [0001] The invention relates to a traditional Chinese medicine compound treatment agent, relates to a pharmaceutical composition for treating climacteric syndrome, in particular to a preparation method of the pharmaceutical composition for treating climacteric syndrome. Background technique [0002] Menopausal syndrome is a series of symptoms caused by a drop in estrogen levels. A small number of women have obvious symptoms because the body cannot adapt quickly, but generally do not need special treatment. Very few symptoms are severe, and even affect life and work, you need to use Chinese medicine Yishen Gengniankang for treatment. It is generally believed that after women enter menopause, changes in their family and social environment can increase their physical and mental burdens, making menopausal syndrome prone to occur or aggravating certain existing symptoms. Some women with unstable mental state themselves have more obvious menopausal syndrome, even...

AI Technical Summary

Problems solved by technology

[0004] At present, there are still many shortcomings in sex hormone replacement therapy, such as increasing the burden on the liver, increasing the incidence of endometrial cancer, breast cancer, thrombotic disease, and cholelithiasis, etc., causing certain risks to women receiving treatment

There are many deficiencies in the external hormone paste that is used now on the market, as because the plaster preparation is to take the package therapy skin ulceration and allergies are not uncommon; the rubber plaster has poor air permeability, irritation to the skin, and the shortcoming of being prone to allergies; The curing time of the plaster is not easy to control, the adhesion is poor, and the paste overflows, etc.

Images